Prostatic adenocarcinoma

Prostatic adenocarcinoma 

Updated: 01/29/2021

© Jun Wang, MD, PhD


General features
  • Predominantly acinar type, less commonly ductal type
  • Most common non cutaneous cancer in men in the United States
  • Predominantly > 50
  • More common in North America, Australia and northern and central Europe
Risk Factors
  • Genetic factors
Ashkenazi Jewish ancestry
BRCA1, BRCA2, Lynch syndrome
CHEK, ATM, HOXB13, etc
  • Environmental factors
High animal fat diet
Cigarette smoking
Obesity, etc
  • Hormones and growth factors
Androgen
Insulin and insulin-like growth factor
  • Protective factors
Lycopenes
Coffee
Soy products
Vitamin D, etc
 
Pathogenesis
  • Hormones, especially androgens and androgen receptor signaling
Amplification/overexpression: Most common
Mutation: Commonly in castrate-resistant cancers, most are gain-of-function mutation
Splice variants: Active AR splice variants (SVs), created by gene splicing or genomic rearrangement
Posttranslational modifications: Phosphorylation, methylation, etc
Intratumoral androgen synthesis

Clinical features
  • Asymptomatic or nonspecific presentations
  • Urinary complaints or retention, back pain, hematuria, etc
  • Symptoms associated with metastasis
Screening approaches
  • Serum prostate specific antigen (PSA)
  • Digital rectal exam
  • Biopsy if abnormal PSA, or rectal exam
Pathological findings
Marker
  • Positive: Racemase, PSA
  • Absence of basal layer: NO reactivity to p63 and 34betaE12
Management
  • Localized tumor
Radical prostatectomy
Radiation therapy
Androgen deprevation therapy
Active surveillance
  • Metastatic cancer:
Rarely curable with current technology
Therapy focus on symptom relief and slow disease progression
  • Prognostic factors: Staging, Gleason grade, tumor volume, capsular status, etc



Back to pathology of male reproductive system
Back to contents

Comments

Post a Comment

Popular posts from this blog

Contents

Pathology notes Jun Wang, MD, PhD 1. General information Frequently discussed syndromes Terms of dermatology Terms of hematology 2. Primary immunodeficiency disorders 3. Hemodynamic abnormalities Shock Thrombosis and embolism Bleeding disorders 4.  Benign blood cell disorders Anemia Benign white cell disorders 5. Hematopoietic neoplasms Lymphoid neoplasms Myeloid neoplasms Histiocytic neoplasms: Langerhans cell histiocytosis 6. Cardiovascular system Pulmonary hypertension Cardiovascular system tumors 7. Respiratory tract tumors 8. Gastrointestinal tract Congenital disorders Infectious gastroenteritis Oral cavity Esophagus Stomach Intestinal tumors Salivary glands Exocrine pancreas and gallbladder 9. Urinary system Kidney masses Lower urinary tract 10. Male reproductive system 11. Female genital tract 12. Breast 13. Endocrine organs Pituitary gland Adrenal gland Thyroid gland Parathyroid gland Endocrine pancreas M
Read more

Anemia

Anemia Updated: 07/13/2024 © Jun Wang, MD, PhD   General features Decrease in red cell mass Hemoglobin: Levels of hemoglobin in a specific volume of whole blood Hematocrit: Fraction of whole blood composed of red blood cells Red cell count: Quantity of red cell in a specific volume of whole blood Three major groups based on RBC sizes Microcytic Normocytic Macrocytic Three major causes Blood loss: acute or chronic Increased red cell destruction: hemolysis Reduced production: marrow failure due to genetic abnormality or nutritional deficiency Etiology Genetic abnormality Hemoglobinopathies RBC cytoskeletal abomorlities Enzyme abnormalities Fanconi anemia Nutritional deficiencies: iron, VB12, folate, general malnutrition Physical etiologies: trauma, burns, frostbite, prosthetic valves, etc Chronic diseases: chronic infections, neoplasia, autoimmune disorders, kidney or liver diseases, etc Infectious diseases: hepatitis, sepsis , malaria, etc
Read more

Lymphoid neoplasms

Lymphocytic neoplasms Updated: 05/17/2020 © Jun Wang, MD, PhD Terminology Lymphoma : Proliferations forming discrete tissue masses Leukemia : Widespread involvement of the bone marrow and usually the peripheral blood Any "lymphoma" can present with or evolve to a leukemic picture, and any "leukemia" can occasionally present with a mass lesion Other hematology terms Important risk factors Immunodeficiency (primary or secondary) Autoimmune disorders Viruses (HIV, KSHV/HHV8, HTLV-1) H. pylori infection Radiation Chemotherapy Diagnostic approaches Complete history, especially those with possible epidemic characters, such as Burkitt lymphoma CBC, Bone marrow Morphology/immunohistochemistry Immunofluorescence flow cytometry Cytogenetic studies Molecular studies Commonly used markers All lymphomas: CD45 B-cell neoplasms: CD5, CD10, CD19, CD20, CD79a, CD23, bcl2, bcl6, cyclin D1, light chai
Read more